1974
DOI: 10.1016/s0140-6736(74)90618-7
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative Bone Scanning: A Method for Assessing Response of Bone Metastases to Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0
2

Year Published

1975
1975
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(6 citation statements)
references
References 2 publications
0
4
0
2
Order By: Relevance
“…Quantitative evaluation, which comprises a method previously investigated in bone tumors (25) , has not been previously applied to stress fractures and sports medicine. To our knowledge, there have been no studies retrospectively or prospectively investigating the application of a semi-quantitative evaluation using the ROI technique in relation to stress fracture outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…Quantitative evaluation, which comprises a method previously investigated in bone tumors (25) , has not been previously applied to stress fractures and sports medicine. To our knowledge, there have been no studies retrospectively or prospectively investigating the application of a semi-quantitative evaluation using the ROI technique in relation to stress fracture outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…Serial bone scans, however, can be used to monitor the response of bone metastases to therapy, either by visual inspection of the images (Galasko and Doyle, 1972;Citrin and McKillop, 1978) or by measuring changes in tumour : normal bone activity ratios (Citrin et al, 1974;Gillespie et al, 1975). Even in patients with other evidence of bone metastases, serial scans are likely to give a more accurate reflection of the patients' status than clinical or radiographic changes (Galasko and Doyle, 1972;Citrin et al, 1974;Citrin and McKillop, 1978).…”
Section: Discussionmentioning
confidence: 99%
“…Less attention was paid to the possibility of using bone seeking radiopharmaceuticals for assessing the response to therapy of osseous metastases, although radioactivity uptake of metastatic bone lesions has been found to be diminished after irradiation (2,4,7,8), chemotherapy and/or hormonal treatment (3,5,6,10,11,12,13). Work published on this subject has not yet clarified completely the type of scintigraphic changes to be expected in responding patients, because unchanged positive scintigrams were also found during successful treatment of osseous metastases (1,9) and initially, during the first months, some authors even registered an increased uptake after therapy which was followed by a gradual decline (4, 6, 7).…”
Section: Introductionmentioning
confidence: 99%